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Abstract
Membrane fusion is key to organism homeostasis and occurs when a transport
vesicle fuses with a target compartment, merging the two membranes into one while
releasing the contents of the transport vesicle into the target compartment. This process is
controlled by SNARE proteins. Syntaxin-17 protein plays a crucial role in the fusion of
the autophagosome membrane with the lysosome membrane, allowing for degradation of
misfolded intracellular components and pathogens. Intriguingly, Syntaxin 17 has been
identified as a target of herpesvirus tegument proteins, although the pathological
significance of the Syntaxin 17 and tegument protein interaction is unclear. As a first step
towards characterizing the biochemical and functional interaction between the tegument
proteins and the target SNARE, this study aimed to amplify and introduce the Syntaxin
17 cDNA into a model E. coli for production and purification of Syntaxin 17 protein.
Amplified insert and vector cDNA of the correct size were obtained and verified via gel
electrophoresis. Future research should focus on the transformation of the chimeric
plasmid into competent E. coli. If isolates with the correct size insert were obtained, the
next steps would be sequencing to confirm absence of mutation and proceed to affinity
column protein purification to obtain the pure recombinant proteins.

Keywords: Membrane fusion, Syntaxin 17, SNARE, Degranulation, Tegument protein,
Autophagosome
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Chapter 1: Introduction
Mast cells are key to the detection of and host response to pathogenic infections
(Viret et al., 2018). These cells are resident immune cells that inhabit tissues such as the
connective tissue that underlies epithelial and mucosal tissue (Krystel-Whittemore et al.,
2016). They are referred to as granulocytes because they have granules in their cytoplasm
that contain bioactive molecules that can cause inflammation and an immediate allergic
response (Pejler et al., 2014). The cells not only effect allergic response but are also
responsible for initiation and regulation of the innate and adaptive immune responses
(Theoharides et al., 2010).
Mast cells control immune responses by detecting antigens. Immune response
activation is reliant upon IgE-dependent and IgE-independent mechanisms. IgEindependent activation is not entirely understood but likely occurs when mast cells
encounter eosinophils (Munitz et al., 2003). Mast cell degranulation, the process by
which cytotoxic molecules are released from granules inside mast cells, is activated via
the IgE-dependent mechanism (Krystel-Whittemore et al., 2016). The IgE-dependent
detection system proceeds via mast cells binding IgE antibodies to their Fc receptors
(Theoharides et al., 2010). Mast cell degranulation does not occur until enough IgE
antibodies, already bound to Fc receptors on the mast cell, bind to enough antigens
(Theoharides et al., 2010). This IgE antibody-antigen complex indirectly binds Fc
receptors to the antigens in a process called Fc cross-linking (Caslin et al., 2018). Fc
cross-linking occurs when the Fc receptors cluster together around an antigen, signaling
for degranulation (Caslin et al., 2018). During degranulation, the granules contained
within the mast cell are released to eliminate or flush out pathogens (Theoharides et al.,
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2010). The Fc cross-linking phenomenon and subsequent degranulation is shown in
Figure 1.1. Among other cytotoxic molecules, histamine is one of the contents released
during degranulation (Caslin et al., 2018). Histamine promotes inflammation by binding
to histamine receptors on the surface of cells. Activation of these receptors in the
gastrointestinal tract increases smooth muscle contractions, causing vomiting and
diarrhea (Krystel-Whittemore et al., 2016).

Figure 1.1: Mast Cell Degranulation. The IgE antibodies produced by plasma cells are
bound by Fc receptors on mast cells. The IgE antibodies bind to antigens and signal for
degranulation. Reprinted from Review of Medical Microbiology and Immunology, 11th
Edition, by W. Levinson.
While not entirely understood, it is known that autophagy, the mechanism by
which cytosolic substances are delivered to the lysosome for degradation, is crucial to
mast cell degranulation (Nakano et al., 2011). Mast cell degranulation and autophagy
play cooperative roles in eliminating pathogens. Autophagosomes are thought to derive
from the endoplasmic reticulum (Itakura et al., 2012). The autophagosome is formed
when the isolation membrane elongates and encloses an area of cytoplasm. After the
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autophagosome is formed, the outer membrane fuses with a lysosome causing
degradation, as shown in Figure 1.2.

Figure 1.2: Autophagosome Formation and Lysosomal Fusion. After the isolation
membrane elongates and encloses cytoplasmic contents forming the autophagosome, the
autophagosome is unable to fuse with a lysosome until Stx-17 forms a complex with
SNAP29 and VAMP8. Reprinted from New Insight into Autophagosome-Lysosome
Fusion by Nakamura and Yoshimori, 2017.
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Mast cell degranulation and autophagy require Soluble N-ethylmaleimidesensitive factor attachment protein receptors (SNAREs), which mediate all intracellular
membrane fusion along the secretory and endocytic pathways (Chen et al., 2001).
SNAREs are a family of proteins that mediate the transport and fusion of secretory
vesicles with membranes in mast cells, resulting in degranulation, and mediate the fusion
of autophagosome with lysosome, resulting in degradation of autophagosomal contents
(Palfreyman & Jorgensen, 2010). SNARE proteins and the complexes these proteins form
are of paramount importance to the pathogenic response in the host. Syntaxin 17 (Stx-17)
was found to be an autophagosome-soluble SNARE protein that has a unique hairpin
structure. This structure was found to be mediated by two transmembrane domains that
both contain a glycine zipper (Itakura et al., 2013). It was later revealed that Stx-17
interacts with SNAP29 and Vesicle Associated Membrane Protein 8 (VAMP8), SNAREs
that are required for fusion between autophagosomes and lysosomes.
SNAREs can be divided into two categories, v-SNAREs and t-SNAREs. The vSNAREs are present in the membranes of transport vesicles during budding and tSNAREs are present on the target membrane (Chen et al., 2001). Syntaxins and SNAPs
are t-SNAREs, and VAMPs are v-SNAREs. SNARE complexes form when v-SNAREs
and t-SNAREs interact, inducing a structural stress within their respective membranes.
The membranous stress causes simultaneous fusion of the two membranes and formation
of a pore, as seen in Figure 1.3. The exact mechanism for membrane fusion is not entirely
known, and it is understood that a variety of other proteins are present (Palfreyman &
Jorgensen, 2010).
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Figure 1.3: Trans and Cis-SNARE Complex and Fusion. The v-SNAREs (blue) form
a trans-SNARE complex with the t-SNAREs (red, yellow, and green) on the target
membranes. This trans-SNARE complex exerts inward stress on the membrane, forcing
membrane fusion. After the membranes fuse, the trans-SNARE complex becomes a cisSNARE complex with all SNAREs residing on the same membrane. Reprinted from
Membrane Fusion: Grappling with SNARE and SM Proteins by T. C. Sudhof and J. E.
Rothman, 2009.
Syntaxin-17, a key SNARE in membrane fusion for autophagy, was identified as
a target for infection and proliferation by herpesvirus. Although localized to
mitochondria-ER interfaces and mature autophagosomes, Stx-17 is ubiquitously
expressed (Itakura et al., 2012; Kimura et al., 2018). As a ubiquitously expressed protein,
Stx-17 serves as a potential target for herpesviruses. Herpes simplex virus (HSV) is
sexually transmitted and infects more than 500 million people (Looker et al., 2008).
HSV-1 and HSV-2 can establish latent infections, i.e., the virus become dormants after
initial infection and is reactivated by stressors in sensory neurons, causing lesions upon
reactivation (Whitley & Rolzman, 2001).
5

The complete infective virion is composed of four main structures, the DNA core,
the protein shell or capsid, the tegument, and the surrounding envelope. There are 23
unique tegument proteins in a herpes virion and they have a multitude of functions. Some
of these functions include the transactivation of viral genes, modulation of host protein
expression, and alteration of the immune response (Henaff et al., 2013). Tegument
proteins have also been observed to interact with viral glycoproteins and collect near the
trans-Golgi network, suggesting that the Golgi is the final packaging site of the virion
before release (Henaff et al., 2013). Research has discovered herpesvirus tegument
proteins interacting with the SNARE complex needed to initiate autophagy (Kelly et al.,
2009). A recent study was performed on tegument proteins ORF33 and ORF38 in Kaposi
Sarcoma Herpes Virus (KSHV). These proteins are conserved in all herpesviruses and
were discovered to be required for optimal production of infectious virions (Wu et al.,
2016).
Recent studies have indicated that mast cells could potentially be a long-term
reservoir for herpesviruses, as seen in the study of KSHV (Ayers et al., 2018). Research
into KSHV infected mast cells found evidence that suggests mast cells are permissive to
KSHV infection and gene expression (Ayers et al., 2018). Mast cells were observed for
over two weeks post infection and viral gene expression was noted to be elevated for the
entire duration, further suggesting mast cells as a reservoir for herpesvirus (Ayers et al.,
2018).
Another study found Enterovirus (EV) D68 disrupts autophagic degradation via
inhibition of SNARE complex formation during autophagosome-lysosome fusion. The
proteins forming the SNARE complex responsible for fusion, Stx-17, SNAP29, and
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VAMP8, were monitored after infection of H1HeLa cells with EV-D68. The
autophagosome associated SNAREs Stx-17 and SNAP29 were observed. An increase in
Stx-17 and decrease in SNAP29 were noted. SNAP29 reduction was attributed to
cleavage by protease EV-D68 3C (Corona et al., 2018). It was determined that EV-D68
promoted autophagic signaling but prevented degradative steps of autophagy (Corona et
al., 2018). The decrease in SNAP29 allowed for viral replication, but not degradation.
As mentioned above, Stx-17 plays a key role in fusion of the autophagosome with
the lysosome. Thus, Stx-17 is a key SNARE in the maintenance of homeostasis. Further
study of the targeting of this SNARE and the complex it forms with SNAP29 and
VAMP8 during autophagosome-lysosome fusion by tegument proteins is critical for
understanding and preventing herpesvirus infections. Studying Stx-17 will not only
provide insight into the mechanism by which membrane fusion occurs, but also offer
invaluable data for the targeting mechanism of conserved tegument proteins in
herpesviruses. To perform future research on the interaction between the Stx-17 SNARE
and viral tegument proteins, a readily available supply of the Stx-17 protein is necessary.
It is the goal of this study to insert the Stx-17 gene into a plasmid vector and introduce
the chimeric plasmid into a strain of E. coli for protein synthesis.
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Chapter 2: Materials and Methods
2.1 Study Overview and Plasmid Information
The syntaxin 17 (Homo sapiens) clone was ordered from addgene. The cDNA for
the Stx-17 insert is stored within the E. coli strain HXB_0J82. The strain was ordered
from addgene, catalog number 89942, and the total recombinant plasmid is 7140 bp in
length. The Stx-17 insert is 909 bp. The gene sequence was shipped in a recombinant
plasmid, Figure 2.1, that is unsuitable for gene expression. The Stx-17 gene sequence was
excised from the recombinant plasmid and ligated to a vector containing a sequence for
an isolation protein. The vector pMBP-parallel1 was chosen due to the presence of the
gene for maltose binding protein, MBP, and restriction sites corresponding with enzymes
present in lab. The cDNA for the pMBP-parallel1 vector is stored in the strain
HXB_OC21. The cell origin is C2992, a DH5α derivative. The vector sequence is 6,724
bp in length, as seen in Figure 2.2. Maltose binding protein allows for Stx-17 to be
expressed with a marker that can be used to collect the expressed protein during an
affinity column purification.
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Figure 2.1: pMRXIP-3xMyc-STX17FL Map. The map is of the recombinant plasmid
from addgene prior to plasmid isolation. The portion of the map outlined in red contains
the insert sequence for Stx-17 prior to excision.
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Figure 2.2: pMBP-parallel1 Restriction Enzyme Map. NcoI and XhoI were selected as
the restriction sites for vector pMBP-parallel1.
2.2 Vector Plasmid Inoculation
After obtaining the appropriate vector stock from the freezer, a sterile loop was
applied to the top of the stock. This sterile loop was then spread over an AMP 100 agar
plate allowing room between streaks to allow for the potential isolation of a single
colony. The plate was placed into the 37 ºC incubator overnight.
A single colony was selected and inoculated into a tube with 5 ml of LB and 5 µl
of ampicillin. The tube was left in the 37 ºC shaking incubator overnight.
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2.3 Insert Plasmid Inoculation
The appropriate Stx-17 stock was obtained from the freezer a sterile loop was
applied to the top of the stock. This sterile loop was then spread over an AMP 100 agar
plate as to allow room between streaks and allow for the potential isolation of a single
colony. The plate was placed into the 37 ºC incubator overnight.
A single colony was selected and inoculated into a tube with 5 ml of LB and 5 µl
of ampicillin. The tube was left in the 37 ºC shaking incubator overnight.
2.4 Vector and Insert Plasmid Isolation
The cultures were isolated using the QIAquick Plasmid Isolation kit, category no.
27106. The tube was placed on ice and 1.5 ml was extracted from the tube and placed
into a 2.0 ml tube and centrifuged at 13k rpm for 1 minute at room temperature. The
supernatant was decanted, another 1.5 ml was added, and the tube was centrifuged again.
The supernatant was decanted and the remaining 2 ml from the culture was stored.
The tubes were vortexed to resuspend the pellet. Each tube received 250 µl of
Buffer P1 to aid resuspension. 250 µl of Buffer P2 was added to release the plasmid DNA
from the bacterial cells. The tubes were then inverted 10 times and placed at room
temperature for five minutes. 350 µl of N3 Buffer was added to neutralize the solution.
The tubes were placed on ice for 10 minutes and subsequently inverted 10 times.
The tubes were centrifuged at 13k rpm for 10 minutes at 4 ºC. The supernatant
was transferred to three columns and centrifuged at 13k rpm for 1 minute at room
temperature. The flow through was discarded and 500 µl of Buffer PB was added to the
column to aid DNA binding to the column. Tubes were subsequently centrifuged at 13k
rpm for 1 minute at room temperature to remove any residual buffer. Flow through was
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discarded and 750 µl of Buffer PE was added to the columns to remove excess salts from
the column membrane. The tubes were centrifuged at 13k rpm for 1 minute at room
temperature and the flow through was discarded. The columns were placed back into
their respective tubes and centrifuged twice more to remove residual buffer. The columns
were transferred to sterile 1.5 ml tubes and allowed to sit for 5 minutes. 50 µl of sterilized
Millipore water was added to the membranes of the columns and allowed to sit for 1
minute to elute the bound DNA. The columns were centrifuged at 13k rpm for 1 minute
at room temperature. The flow through was collected and placed back onto the respective
column membranes and centrifuged once more. The flow through was collected and
analyzed via nanodrop machine.
2.5 PCR Amplification of Stx-17 and Gel Electrophoresis Confirmation
Aliquots of 10x pfu buffer, 10 µM forward primer, 10 µM reverse primer, 10 µM
dNTPs, insert template, and pfu DNA polymerase were obtained from the -20 ºC freezer
and allowed to slowly thaw on ice before short centrifugation. While on ice, 40 µl of
sterilized Millipore water, 5 µl of 10x pfu buffer, 1 µl of the 10 µM forward primer, 1 µl
of 10 µM reverse primer, 1 µl of the 10 µM dNTPs, 1 µl of the insert template, and 1 µl
of pfu DNA polymerase were added to a PCR tube. The tube was centrifuged briefly to
mix and placed into the thermocycler.
The protocol for the thermocycler was a 5-minute hold at 94ºC followed by two
main cycles. The first cycle was repeated 5 times and consisted of 94 ºC for 30 seconds,
55 ºC for 30 seconds, and 72 ºC for 55 seconds. The second cycle was run 25 times and
consisted of 94 ºC for 30 seconds, 60 ºC for 30 seconds, and 72 ºC for 55 seconds. Then
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the thermocycler was set to 72 ºC for 10 minutes followed by a 4 ºC hold until removal
from the thermocycler.
A gel electrophoresis was performed to confirm the size of the insert PCR
product. The 0.7% gel was created via combining 0.35 g of agarose with 50 ml of 0.5X
TBE buffer and boiled for 45 seconds, mixed by swirling, boiled for 15 seconds, mixed
by swirling, boiled for another 15 seconds, followed by mixing by swirling. The mixture
was allowed to cool for 10 minutes before pouring into a casting tray with comb. After
solidifying for 45 minutes, the gel was placed into a running tray and the tank was filled
to the max line with 0.5X TBE buffer, covering the gel. On a sterile piece of parafilm, 1
µl of 100 bp DNA ladder, 2 µl of GelRed, and 7 µl of sterilized Millipore water were
gently mixed by pipetting and placed into the first well of the gel. The second well
contained 5 µl of the unpurified PCR product, 2 µl of GelRed, and 3 µl of sterilized
Millipore water. The gel was run for 75 minutes at 80 V and analyzed.
2.6 PCR Purification
The QIAquick PCR Purification Kit, category no. 28104, was used to purify the
insert PCR product. To enable efficient binding of the DNA to the spin column
membrane, 5 volumes (225.0 µl) of PB Buffer were added to 45.0 µl of the PCR product
and mixed by brief centrifugation. A column was placed into a 2 ml collection tube and
the sample mixture was added to the column. To bind the DNA to the membrane, the
column was spun at 13k rpm at room temperature for 1 minute. The flow through was
discarded and the column was placed back into the collection tube. To remove excess
salts from the membrane, 750 µl of Buffer PE was added to the column and centrifuged
at 13k rpm at room temperature for 1 minute. The flow through was discarded and the
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column was placed back in the collection tube. Centrifugation and disposal steps were
repeated twice more. The column was placed into a clean 1.5 ml collection tube. DNA
was eluted by adding 30 µl of sterilized Millipore water directly to the membrane and let
stand for 1 minute. The column was spun for 1 minute at 13k rpm at room temperature.
The flow through was collected and placed directly on the membrane again and let stand
for 1 minute. The column was spun again for 1 minute at 13k rpm at room temperature.
The flow through was analyzed on the nanodrop machine.
2.7 Double Digest of Vector and Insert
The purified Stx-17 PCR product, isolated pMBP-parallel1, 10X NEB Cutsmart
Buffer, XhoI, and NcoI were removed from the freezer and allowed to thaw on ice. After
thawing, they were centrifuged and placed back on ice. Two tubes were prepared and
labeled, Tube A for the Stx-17 insert and Tube B for the pMBP-parallel1 vector. In Tube
A, 33 µl of sterilized Millipore water, 10 µl of the purified Stx-17 PCR product, 5 µl of
the 10X NEB Cutsmart Buffer, 1 µl of the NcoI enzyme, and 1 µl of the XhoI enzyme
were added. In Tube B, 32.5 µl of sterilized Millipore water, 10.5 µl of isolated pMBPparallel1, 5 µl of 10X NEB Cutsmart Buffer, 1 µl of NcoI enzyme, and 1 µl of the XhoI
enzyme were added. Both tubes were briefly centrifuged to make sure they were evenly
mixed and placed into a 37 ºC water bath for 3 hours. After the water bath, both tubes
were briefly centrifuged again and placed on a 65 ºC heat block for 20 minutes to
neutralize digestion by the enzymes. Tube A, the insert, was placed into the -20 ºC
freezer. Tube B, the vector, was treated with 1 µl of rSAP to remove any unincorporated
dNTPs, briefly centrifuged, and placed in a 37 ºC water bath for 1 hour. Afterwards, Tube
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B was centrifuged and placed on a 65 ºC heat block for 20 minutes to neutralize the
rSAP. Tube B was placed into the -20 ºC freezer with Tube A.
2.8 Gel Electrophoresis Confirmation
A gel electrophoresis was performed to confirm the size of the digested products
and to prepare them for gel extraction purification. As before, the 0.7% gel was created
by combining 0.35 g of agarose with 50 ml of 0.5X TBE buffer and boiled for 45
seconds, mixed by swirling, boiled for 15 seconds, mixed by swirling, boiled for another
15 seconds, followed by mixing by swirling. The mixture was cooled for 10 minutes at
room temperature before pouring into a casting tray with comb. Unlike before, wells 2
and 3 along with 5 and 6 were combined to allow for all of the digested contents of Tubes
A and B to be placed in one well. After solidifying for 45 minutes, the gel was placed
into a running tray and the tank was filled to the max line with 0.5X TBE buffer,
covering the gel. On a sterile piece of parafilm, 1 µl of 1kb DNA ladder, 2 µl of GelRed,
and 7 µl of sterilized Millipore water were gently mixed by pipetting and placed into the
first well of the gel. The combined well of lanes 2 and 3 contained all of the contents of
Tube A mixed with 2 µl of GelRed. Well 4 was left empty to allow enough separation
between the large combined wells. Combined wells 5 and 6 contained all of the digested
contents of Tube B along with 2 µl of GelRed. The gel was run for 75 minutes at 80 V
and analyzed under the orange UV box to prevent damage to the DNA bands.
2.9 Vector and Insert Gel Extraction
Using a clean scalpel for each band, the digested Stx-17 insert band and pMBPparallel1 vector band were excised from the gel and each placed into a clean 2 ml tube of
known weight. Each tube was weighed again to find the weight of the gel and band
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contained in each respective tube. Using the QIAquick Gel Extraction Kit, category no.
28704, band extraction began.
Both bands weighed 130 mg, so 390 µl of Buffer QG (3 volumes) were added to
each tube to solubilize the agarose gel that the band is contained in. Each tube was placed
on a 55 ºC heat block and vortexed every 2 minutes for 10 minutes. The mixture was
monitored to remain yellow. To precipitate the DNA from solution, 130 µl of isopropanol
(1 volume) was added. A column was placed into a 2 ml collection tube and the mixture
was added. The column was centrifuged at 13k rpm for 1 minute at room temperature and
the flow through was discarded. 500 µl of Buffer QG was added and the column was
centrifuged at 13k rpm for 1 minute at room temperature. The flow through was
discarded and 750 µl of Buffer PE was added. The column was left to stand for 5 minutes
and subsequently centrifuged at 13k rpm for 1 minute at room temperature. Flow through
was discarded and the column was spun one more time. The column was placed into a
clean 1.5 ml collection tube and 30 µl of sterilized Millipore water was added directly to
the membrane of the column. The column was left to stand for 5 minutes and then
centrifuged at 13k rpm for 1 minute at room temperature. The flow through was collected
and analyzed via nanodrop.
2.10 Vector and Insert Ligation
It was determined that a 4:1 ratio would be needed and the vector, pMBPparallel1, would be required in a 50 ng amount. It was determine via equation,
4 × (insert bp/vector bp)(50 ng) = insert ng, that the insert would be required in a 27.04

ng amount. The nanodrop values collected for the vector and insert after gel extraction
were used to determine that 2.8 µl of vector pMBP-parallel1 and 2.0 µl of insert Stx-17
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would be required for the ligation reaction. The NEB T4 DNA Ligase, 10X T4 DNA
Ligase Buffer, and gel purified products were removed from the -20 ºC freezer and
allowed to thaw on ice and briefly centrifuged.
Two tubes were prepared on ice, Tube A for the actual ligation of insert and
vector while Tube B contained the vector only as a negative control. In Tube A, 2.7 µl of
sterilized Millipore water, 2.0 µl of Stx-17, 2.8 µl of pMBP-parallel1, 1.5 µl of 10X T4
DNA Ligase Buffer, and 1 µl of T4 DNA Ligase were added. In Tube B, 4.7 µl of
sterilized Millipore water, 2.8 µl of pMBP-parallel1, 1.5 µl of 10X T4 DNA Ligase
Buffer, and 1.0 µl of T4 DNA Ligase were added.
The tubes were both briefly centrifuged to thoroughly mix the contents of each.
Both tubes were then placed in a thermocycler for 17 hours at 17 ºC.
2.11 Recombinant Plasmid Transformation into NovaBlue Cells
Aliquots of NovaBlue cells from the -80 ºC freezer along with ligation products A
and B from the -20 ºC freezer were removed and allowed to thaw on ice. All tubes were
gently mixed after thawing by flicking. In separate tubes, 2 µl of ligation products A and
B were mixed with 20 µl of NovaBlue competent cells. As a positive control to ensure
the NovaBlue cells were viable, a third tube was prepared with 20 µl of competent cells
and 1 µl of PUC. All tubes were mixed via gentle flicking and placed on ice for 45
minutes. All tubes were placed on a heat block for 45 seconds at 42 ºC. All tubes were
then placed on ice for 30 minutes. To aid in molecular uptake and recovery of the
competent cells, 100 µl of SOC media was added to tubes A and B. The third positive
control tube received a mixture of 110 µl of LB and 10 µl SOC media. To further aid in
recovery, all tubes were placed in 37 ºC incubator for 1 hour. During incubation, 3 AMP
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100 agar plates were prepared and labelled. After recovery, the tubes were centrifuged for
5 minutes at 4k rpm at room temperature. Most of the supernatant was removed and the
pellets were resuspended. Each sample was plated onto their respective plates. All plates
received 7 glass beads and were rotated vigorously for 15 seconds to thoroughly spread
the sample through the plate. Plates were placed in the 37 ºC incubator for 20 minutes
facing up so the samples were able to absorb into the agar. After the 20 minutes, the
plates were flipped over and left overnight in the 37 ºC incubator.
2.12 Potential Transformation Isolation
Three separate colonies on the transformation plate were inoculated into three test
tubes containing 5 ml of LB and 5 µl of AMP 100. These three tubes were placed into the
37 ºC shaker incubator overnight. The tubes were removed and placed on ice. 1.5 ml was
extracted from each tube and placed into a corresponding 2.0 ml tube and centrifuged at
13k rpm for 1 minute. The supernatant was decanted and another 1.5 ml was added to the
respective tube and centrifuged. The supernatant was decanted, and the remaining 2 ml
was stored.
Using QIAquick Plasmid Isolation Kit, category no. 27106, chimeric plasmid
isolation continued. Each tube was vortexed until the pellet disappeared and received 250
µl of Buffer P1 to resuspend. This was followed by the addition of 250 µl of Buffer P2, a
lysis buffer that allows for the release of plasmid DNA from bacterial cells. The tubes
were then inverted 10 times and placed at room temperature for five minutes. Next 350 µl
of N3 Buffer was added to neutralize the solution. The tubes were placed on ice for 10
minutes and subsequently inverted 10 times.
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The tubes were centrifuged at 13k rpm for 10 minutes at 4 ºC. The supernatant
was transferred to three columns and centrifuged at 13k rpm for 1 minute at room
temperature. The flow through was discarded and 500 µl of Buffer PB was added to the
column to aid DNA binding to the column. Tubes were subsequently centrifuged at 13k
rpm for 1 minute at room temperature to remove any residual buffer. Flow through was
discarded and 750 µl of Buffer PE was added to the columns to remove excess salts from
the column membrane. The tubes were centrifuged at 13k rpm for 1 minute at room
temperature and flow through was discarded. The columns were placed back into their
respective tubes and centrifuged twice to remove any residual buffer. The columns were
transferred to 1.5 ml tubes and allowed to sit for 5 minutes. To elute the DNA, 50 µl of
sterilized Millipore water was added to the membranes of the columns and allowed to sit
for 1 minute. The columns were centrifuged at 13k rpm for 1 minute at room
temperature. The flow through was collected and placed back onto the respective column
membranes and centrifuged once more. The flow through was collected and analyzed by
nanodrop.
2.13 Double Digestion and Gel Electrophoresis Confirmation
Colony Forming Unit (CFU) B, the sample with the highest concentration at 68.1
ng/µl, was selected for double digestion and gel electrophoresis. On ice, 28 µl of
sterilized Millipore water, 15 µl of the potential plasmid, 5 µl of the 10X NEB Cutsmart
Buffer, NcoI enzyme, and XhoI enzyme were added to a tube. The tube was placed in a
37 ºC water bath for 1 hour. Subsequently, the tube was briefly centrifuged and placed on
a 65 ºC heat block for 20 minutes to neutralize the enzymes.
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Two gel electrophoresis were performed on the sample. The first gel was 0.7%
and contained 1 µl of 1kb ladder, 2 µl of GelRed, and 7 µl of sterilized Millipore water in
the first well. The second well contained 6 µl of the double digested CFU B, 2 µl of
GelRed, and 2 µl of sterilized Millipore water. The gel was run for 75 minutes at 80V and
analyzed under the imager.
On the second 0.7% gel, the double digested and undigested CFU B samples were
run. Well 1 contained 1 µl of 1kb ladder, 2 µl of GelRed, and 7 µl of sterilized Millipore
water. The second well contained 4 µl of sterilized Millipore water, 4 µl of undigested
recombinant plasmid, and 2 µl of GelRed. The third well contained 4 µl sterilized
Millipore water, 4 µl of double digested recombinant plasmid, and 2 µl of GelRed. The
gel was subsequently imaged and analyzed.

Chapter 3: Results
To investigate the biochemical and functional interaction between the tegument
proteins and Stx-17, a readily available supply of the SNARE protein is necessary. The
experiments performed explored the concept of Stx-17 cDNA transformation into E. coli
strain suitable for protein production. Due to the presence of maltose binding protein and
prior experience in the research lab, pMBP-parallel was chosen as the vector. Samples of
the vector and insert were plated on their respective plates and colonies were allowed to
grow overnight. The next day colony forming units, CFUs, were isolated and the
concentrations were analyzed via nanodrop machine. The nanodrop measures absorbance
and calculates the concentration of nucleic acids. The pMBP-parallel1 sample was
determined to have a 94.1 ng/µl concentration and had A260/280 and A260/230 of 1.84
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and 2.12, respectively (Table 3.1). The Stx-17 sample was determined to have a 385.1
ng/µl concentration and had A260/280 and A260/230 of 1.87 and 2.31, respectively
(Table 3.1). These values indicate the sample contained a high concentration of vector
and the sample was pure. This was determined because a A260/280 value around 1.8
indicates a pure DNA sample without proteins contamination. Also, a A260/230 value
around 2 indicates the presence of no unwanted organic compounds.

Table 3.1: Concentration of Vector and Insert Plasmid Isolation.
Plasmid/Strain

Concentration: ng/µl

A260/280 A260/230

pMBP-parallel1/HXB_OC21

94.1

1.84

2.12

Stx-17/HXB_OJ82

385.1

1.87

2.31

To obtain a workable amount of Stx-17 cDNA, PCR was performed on the insert
sample. Gel electrophoresis was performed prior to PCR purification to verify the band
size of the insert. The unpurified insert PCR product was run on a 0.7% gel with a 100 bp
ladder to determine the size of the sample (Fig 3.1). The unpurified insert PCR product
band appeared between the 1000 bp and 1150 bp bands despite the insert being 909 bp in
length.
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Figure 3.1: Unpurified Stx-17 PCR Gel Electrophoresis.
Lane 1 contained 1 µl of 100 bp DNA ladder, 2 µl of GelRed, and 7 µl of sterilized
Millipore water. Lane 2 contained 5 µl of the unpurified PCR product, 2 µl of GelRed,
and 3 µl of sterilized Millipore water.
Although the insert band appeared to have more base pairs on the gel
electrophoresis than anticipated, the sample was purified, and the concentration was
analyzed via nanodrop. The sample was determined to have a 99.1 ng/µl concentration
and had A260/280 and A260/230 values of 1.8 and 2.5, respectively (Table 3.2).
Although 2.5 is slightly higher that the desired number, it was not high enough to indicate
any serious contamination.

Table 3.2: Concentration of Purified Insert Stx-17 PCR Product.
Sample

Concentration: ng/µl

A260/280

A260/230

Stx-17

99.1

1.8

2.5

The vector and purified insert samples were prepared for ligation by double
digestion and purified by gel extraction. Double digestion created sticky ends, conducive
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for ligation. Following digestion, the samples were run alongside a 1kb ladder to confirm
their sizes and to extract the corresponding bands (Fig 3.2). Double digested Stx-17
presented between 1,000 and 1500 bp. The double digested pMBP-parallel1 began
around the 6,000 bp band.

Figure 3.2: Double Digested Insert and
10
8.0
6.0
5.0
4.0
3.0
2.0
1.5

Vector Prior to Gel Extraction. Lane 1
contained 1 µl of 1kb ladder, 2 µl of
GelRed, and 7 µl of sterilized Millipore

1.0

water. Combined lanes 4 and 5 contained 2

0.5

µl of GelRed and 50 µl of the double
digested insert, Stx-17. Combined lanes 6
and 7 contained 2 µl of GelRed and 50 µl of
the double digested vector, pMBP-parallel1.

Once the excised bands underwent gel extraction, their nanodrop concentrations
were taken. The concentrations of the double digested insert and vector were not retained
after the gel extraction indicated by Table 3.3. An insert value of 19.7 and vector value of
17.9 indicated low concentrations and absorption values of 1.9 and 0.1 for both samples
indicate impurities. The double digested samples were not concentrated, nor were they
pure.
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Table 3.3: Concentration of Gel Extracted Insert and Vector After Restriction
Double Digestion.
Plasmid Sample

Concentration: ng/µl

A260/280

A260/230

Stx-17

19.7

1.9

0.1

pMBP-parallel1

17.9

1.9

0.1

Despite receiving low gel extraction values, the samples underwent a gel
electrophoresis to confirm their size prior to ligation. The results from the ladder are
inconclusive as the ladder did not run properly; however, Stx-17 appears to be
concentrated around the 1,500 bp band and pMBP-parallel1 begins slightly before the
8,000 bp band and ends around the 10,000 bp band (Fig 3.3). These values indicate the
samples are heavier than they should be.

Figure 3.3: Gel Purified and Double Digested Insert and
Vector.
10.0
8.0
6.0
5.0
4.0
3.0
2.0
1.5
1.0

Lane 1 contains a 1 kb ladder that did not separate properly
during the run. Lanes 2 and 3 contained the 4 µl of gel
extracted Stx-17 and pMBP-parallel1 samples, 2 µl
GelRed, and 4 µl of sterilized Millipore water, respectively.

0.5
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Although the concentration values and gel bands did not confirm what was
expected, the insert and vector were ligated, transformed, and plated twice. Three plates
were created for each attempt. Plate #1 was the insert and vector, #2 was the vector only,
and #3 was the competent cells only. Plate #2 was to ensure vector did not fold and ligate
back onto itself, this plate was not supposed to have any growth. Plate #3, contained only
the NovaBlue competent cells, was to confirm the viability of the cell line and to serve as
a positive control. The first attempt did not see any CFUs grow on #1 or #2 (Fig 3.4). The
second attempt saw 27 CFUs grow on Plate #1 after two days in the incubator (Fig 3.5).
The second attempt Plate #2 did not see any CFUs (Fig 3.5).

#2

#1

#3

Figure 3.4: Transformation Plates for Stx-17/pMBP-parallel1 (Plate #1), pMBPparllel1 only (Plate #2), and NovaBlue competent cells only (Plate #3).
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Figure 3.5: Second Transformation Plate for Stx-17/pMBP-parallel1.
Three colonies were isolated from the insert and vector plate and underwent
plasmid isolation. CFU A and CFU C did not have a high concentration of plasmid, nor
were their A260/230 values close to the recommended 2-2.2 threshold, indicating the
samples were not pure either (Table 3.4). CFU B had a much higher concentration than
the other isolated CFUs. Although none of the isolated CFUs showed pure absorption
values, CFU B displayed a concentration high enough to perform double digestion and
gel electrophoresis.

Table 3.4: Concentration of Three Isolated CFUs from Transformation Plate.
Potential Transformation Sample

Concentration: ng/µl

A260/280

A260/230

Potential CFU A

13.6

1.53

0.55

Potential CFU B

68.1

1.54

0.58

Potential CFU C

5.3

1.54

0.53
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Potential CFU B was double digested and two gels were run for band size
confirmation in Fig 3.6 and Fig 3.7. The first gel (Fig 3.6) indicated faint bands at
approximately the desired size. The first band at 1,000 bp corresponds with the size of
Stx-17 at 909 bp. The second band at around the 8,000 bp mark could correspond to
pMBP-parallel1 at 6,724 bp. The band at the top of the gel may correspond to relaxed
DNA that was not properly digested and did not travel far.
The sample was run a second time to confirm the size seen in Fig 3.7. Both
digested and undigested were run; however, no bands appeared. As seen in Fig 3.7, lane 1
contains the 1 kb ladder and lanes 2 and 3 contain the undigested and double digested
CFU B, respectively. No bands are visible in lanes 2 or 3. Lane 2 should have seen a
band around 8,000 bp for the undigested plasmid. Lane 3 should have seen bands at 1,000
bp for the insert and 7,000 bp for the vector.

Figure 3.6: Possible Stx-17/pMBP-parallel1 Transformation
Double Digest Gel Electrophoresis.
Red boxes indicate a potential band at 1,000 bp corresponds with
the size of Stx-17 at 909 bp, a second band at around the 8,000 bp
mark could correspond to pMBP-parallel1 at 6,724 bp, and a band
at the top of the gel may indicate relaxed DNA that was not
properly digested and did not travel far.
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Figure 3.7: Isolated CFU B Undigested and Double
Digested.
No bands were observed for the undigested and double
digested CFU B.

Chapter 4: Discussion
Results from the double digested transformation plate isolate yielded inconclusive
results. The second transformation attempt saw only 27 CFUs around the edge of the
plate after two days in the incubator. This could indicate slow growing colonies or that
the AMP100 selection was no longer effective by the second day allowing false colonies
to grow on the plate. Because the colonies grew on the edge of the plate, this could
indicate that the glass beads were not properly rolled as to spread the sample across the
whole plate or that contamination reached the edge of the plate. Despite potentially being
false colonies, 3 CFUs were isolated towards the center of the plate and purified. In spite
of low A260/230 values, the CFU with the highest concentration was double digested.
The double digested potential recombinant plasmid on Fig 3.6 corresponds
roughly to what was expected; however, the vector band should have been between 6kb
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and 8kb instead of between 8kb and 10kb because pMBP-parallel1 is 6,724 bp. When
reviewing the results with what was expected, it was not unheard of for the band to
appear slightly heavier than it should be. Despite this, the results obtained from this
isolation are inconclusive. The faint band at 1kb corresponds with Stx-17 insert that has
909 bp. The band at the top of the gel could potentially be undigested DNA that was
nicked during the digestion and may have relaxed some of the super coiling, causing the
band to not travel as far. When the gel was run again with the undigested and double
digested plasmid, no bands appeared (Fig 3.7). This is interesting because the
concentration of the isolated CFU B was only slightly reduced to conserve sample for
potential sequencing.
It is likely that CFU B was a false positive or did not have a high enough
concentration to be valuable. Currently, the data is inconclusive as to whether the ligation
and transformation were successful. If the correct bands had been identified for the
isolated transformation colony, the sample would need to be sent off for sequencing.
Once the sequence had been obtained, it would need to be analyzed alongside the
confirmed nucleotide sequence on the NCBI website. If any mutations had been detected,
transformations would need to be performed again to obtain a more faithful DNA sample.
After confirmation, protein isolation from the cell cultures would follow.
Addressing the low concentration for the gel extraction, the double digested
vector and insert the bands were not exposed to UV light so the samples should not have
been mutated or damaged. Despite this, high concentrations for the insert and vector
could not be obtained. The gel extraction was performed three times. The gel slices were
cut as close to the bands as possible, the gel fragments were allowed to completely
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dissolve, and the 30 µl of sterilized Millipore water were applied directly to the
membrane of the column and allowed to stand for 5 minutes before centrifugation.
When looking into gel extraction, low concentrations are common with the
QIAquick Gel Extraction Kit, category no. 28704. Two potential issues discovered are if
the spin columns are not properly sealed in their bags the membranes have the potential
to dry out and if too high of a concentration is being applied to the column, the membrane
will not be able to absorb all of the sample. Two possible solutions include obtaining new
columns and sealing their bag between use or using multiple columns for high
concentration.
Stx-17 plays a pivotal role in membrane fusion and is a target for herpesvirus
tegument proteins. It is crucial to obtain a deeper understanding of this protein and to
develop a method for producing it so it can be studied. Future research into this protein
should pick up prior to the Gel Extraction step and focus on obtaining higher
concentrations and more pure samples. When these samples are obtained, successful
ligation and transformation will be more likely. After a successful transformation and
isolation, sequencing will need to be performed to confirm the sample. Then protein
affinity isolation can be used to purify the protein using the MBP tag. Confirmation of the
protein production will allow for the method to be scaled up to produce an abundant
supply of Stx-17 protein. Once a successful method of supplying Stx-17 is established,
further research on herpesvirus interaction with this SNARE can be performed.
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